Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 2 19Phase 4 4Phase 3 4Phase 1/2 4Phase 1 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 74Recruiting 54Terminated 28Active not recruiting 24Unknown 9Withdrawn 6Not yet recruiting 3Suspended 2

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 2Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Leukemia, Myeloid, Acute 26Colorectal Neoplasms 26Neoplasms 24Neoplasm Metastasis 23Recurrence 22Multiple Myeloma 22Advanced Solid Tumors 19Lymphoma, B-Cell 18Breast Neoplasms 18Lung Neoplasms 14Pancreatic Neoplasms 13Glioblastoma 13Melanoma 12Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Lymphoma 11Glioma 11Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Ovarian Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Esophageal Neoplasms 8

Interventions

ceralasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Endometrial Neoplasms × Clear all
NCT07383506 2026-03-27

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Cogent Biosciences, Inc.

Phase 1 Not yet recruiting
90 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT06754761 2025-01-01

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

AstraZeneca

Phase 1 Not yet recruiting
8 enrolled
GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Danatlas Pharmaceuticals Co., Ltd

Phase 1 Not yet recruiting
112 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡